S

Stereotaxis
D

STXS

2.23000
USD
-0.06
(-2.41%)
Market Closed
Volume
5,088
EPS
-0
Div Yield
-
P/E
-8
Market Cap
188,946,801
Related Instruments
    ABT
    ABT
    0.850
    (0.74%)
    118.950 USD
    BSX
    BSX
    -0.590
    (-0.67%)
    87.000 USD
    C
    COO
    -0.230
    (-0.23%)
    99.640 USD
    D
    DGX
    3.615
    (2.30%)
    160.455 USD
    H
    HOLX
    1.040
    (1.34%)
    78.600 USD
    ISRG
    ISRG
    -10.30
    (-1.92%)
    538.87 USD
    L
    LH
    -3.029
    (-1.27%)
    235.180 USD
    MDT
    MDT
    1.520
    (1.77%)
    86.310 USD
    SYK
    SYK
    6.90
    (1.80%)
    387.88 USD
    TMO
    TMO
    -19.95
    (-3.74%)
    521.81 USD
    More
News

Title: Stereotaxis

Sector: Healthcare
Industry: Medical Instruments & Supplies
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, andinformation solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.